Risks of PEG tube placement in patients with cirrhosis-associated ascites

Figures & data

Table 1 Target population demography

Demographic	Percentage
Age, years, mean	61.14
Sex, n (%)
Male	380 (65.2)
Female	203 (34.8)
Race, n (%)
White	359 (64.4)
African American	90 (14.8)
Hispanic	84 (13.7)
Asian	23 (3.3)
Native American	7 (0.4)
Other	20 (3.5)
Mean length of stay in days	15.84

Table 2 Complication from percutaneous endoscopic gastrostomy tube placement

Complication	Ascitis 107 vs non-ascitis 476		P-value	Odds ratio	95% CI
Postoperative bleeding	4 (0.8%)	2 (1.9%)	0.35	2.244	0.45–12.3
Surgical site infection	2 (0.4%)	1 (0.9%)	0.51	2.23	0.2–2.4
Urinary tract infection	105 (22.1%)	34 (23.8%)	0.34	1.6	1.03–2.6
Colonic injury	0.00	0.00

Table 3 Risk factor and inpatient mortality

Condition	P-value	Odds ratio	95% CI
Esophageal varices	0.97	1.02	0.29–3.53
Ascites	0.115	1.5	0.89–2.86
Sex	0.496	0.83	0.48–1.41
Race	0.002	0.145	0.9–1.67
Congestive heart failure	0.097	1.67	0.911–3.08
Lung disease	0.353	1.3	0.748–2.25
Diabetes mellitus	0.138	1.5	0.87–2.67
Hypertension	0.085	0.6	0.38–1.06
Obese	0.411	1.4	0.61–3.25
Urinary tract infection	0.769	1.0	0.60–1.95
Postoperative bleeding	0.289	2.5	0.45–14.2
Surgical site infection	0.941	0.9	0.09–5.80